Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure-Reference-Cited by-同舟云学术

Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure

Published:2022-04 Issue: Volume:618 Page:121658
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Dimiou Savvas,Lopes Rui M.,Kubajewska Ilona,Mellor Ryan D.,Schlosser Corinna S.,Shet Manjunath S.,Huang Hugh,Akcan Ozgur,Whiteside Garth T.,Schätzlein Andreas G.,Uchegbu Ijeoma F.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference55 articles.

1. Levodopa: the story so far;Abbott;Nature,2010

2. Blood-brain barrier structure and function and the challenges for CNS drug delivery;Abbott;J Inherit Metab Dis,2013

3. Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying;Anand Kumar;Proc Natl Acad Sci U S A,1982

4. In vitro and in vivo evaluation of levodopa-loaded nanoparticles for nose to brain delivery;Arisoy;Pharm Dev Technol,2020

5. Protective and symptomatic strategies for therapy of Parkinson's disease;Blandini;Drugs Today (Barc),1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Targeting Nanomedicines: Pitfalls and Promise;International Journal of Nanomedicine;2024-05

2. Multifunctional systems based on nano-in-microparticles as strategies for drug delivery: advances, challenges, and future perspectives;Expert Opinion on Drug Delivery;2023-09-02

3. Levodopa-loaded nanoparticles for the treatment of Parkinson's disease;Journal of Controlled Release;2023-08

4. Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders;Biomedicines;2022-07-14